Zobrazeno 1 - 10
of 100
pro vyhledávání: '"H I Robins"'
BACKGROUND: Treatment options for recurrent high-grade glioma are limited. We updated a retrospective series of treatment completed pulsed reduced dose rate radiation therapy (PRDR), a method to decrease toxicity and improve efficacy. METHODS: 103 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0478cb4db7c7571793cdbd1f319f3665
https://europepmc.org/articles/PMC6217590/
https://europepmc.org/articles/PMC6217590/
Autor:
M. K. Behera, A. Sharma, S. Dutta, S. Sharma, P. K. Julka, G. K. Rath, W. J. Kil, C. Ko, A. Kaushal, K. Warran, H. Ning, K. Camphausen, D. Smart, T. Z. Vern-Gross, K. P. McMullen, L. D. Case, J. D. Bourland, T. L. Ellis, J. A. Lawrence, S. B. Tatter, E. G. Shaw, J. J. Urbanic, M. D. Chan, R. L. Jensen, D. C. Shrieve, P. Mohindra, H. I. Robins, W. A. Tome, S. P. Howard, C. Chen, D. Damek, L. E. Gaspar, D. Ney, A. Waziri, K. Lillehei, B. D. Kavanagh, C.-C. Wang, S. Floyd, C.-H. Chang, P. Warnke, C.-C. Chio, E. Kasper, A. Mahadevan, E. Wong, S. Jeyapalan, A. Mahajan, D. Grosshans, M. F. McAleer, P. D. Brown, M. Chintagumpala, T. Vats, V. Puduvalli, T. Yock, M. Schulder, Y. Herschmann, M. Ghaly, J. Knisely, A. Kapur, P. Goetz, S. Lwu, J. Ebinu, M. Arayee, E. Monsalves, N. Laperriere, C. Menard, M. Bernstein, G. Zadeh, A. G. Loganathan, N. Alphonse, A. M. Peiffer, A. Johnson, P. A. Saconn, M. T. Munley, M. Aryaee, C. Lowe, J. DeGroot, G. Mark, R. Ruda, E. Trevisan, U. Magliola, L. Bertero, C. Bosa, U. Ricardi, R. Soffietti, P. Rajappa, K. Margetis, A. G. Wernicke, D. L. Sherr, E. Lavi, R. L. Fine, T. Schwartz, S. C. Pannullo, N. Laack, M. Blanchard, J. Buckner, J. Glass, D. W. Andrews, M. Werner-Wasik, J. Evans, Y. R. Lawrence, W. Shi, I. Strauss, B. W. Corn, D. Matceyevsky, S. Alani, E. Gez, N. Shtraus, A. A. Kanner, M. Spasic, W. Choy, D. Nagasawa, I. Yang, M. Noel, E. Woolf, R. Smith, P. Castillo-Rojas, S. Sorenson, K. Smith, A. C. Scheck, S. J. Han, M. C. Oh, M. E. Sughrue, M. J. Rutkowski, D. Aranda, I. J. Barani, A. T. Parsa, K. J. Redmond, A. Horska, O. Ishaq, E. Ford, T. McNutt, S. Batra, L. Kleinberg, M. Wharam, M. Mahone, S. Terezakis, S. Ryu, J. Rock, B. Movsas, T. Mikkelsen, M. Rosenblum, D. Sabsevitz, J. A. Bovi, P. Leo, P. LaViolette, S. Rand, W. Mueller, A. Phillips, R. Venkatramani, A. Olch, J. Grimm, T. Davidson, R. Brown, G. Dhall, J. Finlay, K. Wong
Publikováno v:
Neuro-Oncology. 13:iii127-iii133
Autor:
Tito R. Mendoza, Terri S. Armstrong, Antonio Omuro, Kenneth Aldape, Tom Mikkelsen, Patrick Y. Wen, Mark R. Gilbert, Elizabeth R. Gerstner, Elizabeth Vera, Jing Wu, Jimin Wu, H. I. Robins, Ying Yuan, Frank S. Lieberman
Publikováno v:
Neuro-Oncology. 20:vi241-vi241
BACKGROUND: Ependymoma is a rare tumor for which the role of chemotherapy has not been established either for newly diagnosed or recurrent disease. We report on the first prospective adult clinical trial of chemotherapy for recurrent ependymoma. METH
Autor:
A. Charkravarti, M. Wang, I. Robins, A. Guha, W. Curren, D. Brachman, C. Schultz, A. Choucair, M. Dolled-Filhart, J. Christiansen, M. Gustavson, A. Molinaro, P. Mischel, T. Lautenschlaeger, A. Dicker, M. Mehta, C. A. Phillips, S. Dhulibala, D. Hallahan, J. Jaboin, F. S. Cardinale, P. Dickey, I. Goodrich, J. Gorelick, R. Sinha, V. M. Dest, C. Chen, C. Olsen, W. Franklin, B. Kleinschmidt-DeMasters, B. D. Kavanagh, K. Lillehei, A. Waziri, D. Damek, L. E. Gaspar, M. C. Stauder, N. N. Laack, M. J. Link, B. E. Pollock, P. J. Schomberg, J. F. Fraser, S. C. Pannullo, J. Moliterno, W. Cobb, P. E. Stieg, S. Vinchon-Petit, D. Jarnet, S. Michalak, A. Lewis, J.-P. Benoit, P. Menei, G. Desmarais, B. Paquette, R. Bujold, D. Mathieu, D. Fortin, K. C. Cuneo, J. J. Vredenburgh, J. H. Sampson, D. A. Reardon, A. Desjardins, K. L. Peters, J. P. Kirkpatrick, P. N. Patel, R. Vyas, U. Suryanarayan, D. Bhavsar, C. Hayhurst, E. Monsalves, M. Van Prooijen, C. Menard, G. Zadeh, C. Chung, K. Burrell, P. Lindsey, S. H. Burri, A. L. Asher, R. B. Kelly, P. Boltes, R. W. Fraser, F. A. Dilmanian, A. Rusek, N. R. Desnoyers, J. Y. Park, B. Dane, I. Dioszegi, S. D. Hurley, M. K. O'Banion, D. Tomasi, R. Wang, A. G. Meek, L. Sleire, J. Wang, J. Heggdal, P.-H. Pedersen, P. O. Enger, D. A. Clump, R. Srinivas, R. E. Wegner, D. E. Heron, S. A. Burton, A. H. Mintz, S. P. Howard, H. I. Robins, W. A. Tome, A. J. Paravati, P. A. Gardner, C. Snyderman, C. Ozhasoglu, A. Quinn, K. Seelman, J. H. Chang, Y. G. Park, M. J. Mehta, R. K. Vyas, D. C. Bhavsar, J. N. Guarnaschelli, L. Imwalle, J. Ying, C. McPherson, R. Warnick, J. Breneman, S. S. Khwaja, N. M. Wetjen, P. D. Brown, M. Siedow, U. Nestler, J. Perry, A. Huebner, A. Chakravarti, J. Glass, D. Andrews, M. Werner-Wasik, J. Evans, R. Lawrence, N. Martinez, G. Anuradha, M. David, M. Sara, L. Mark, B. Ricardo, J. Jeff, H. Juan, D. Kozono, P. Zinn, K. Ng, E. Melian, V. Prabhu, A. Sethi, K. Barton, D. Anderson, R. C. Rockne, M. Mrugala, J. Rockhill, K. R. Swanson
Publikováno v:
Neuro-Oncology. 12:iv105-iv112
Publikováno v:
Neuro-oncology practice. 2(4)
Autor:
P.Z. Vörde sive Vörding, A. Bakhshandeh, H. Bailey, C L Tiggelaar, G. J. Wiedemann, Dirk Jäger, Walter L. Longo, A.M. Westermann, W. Gillis, Dörthe M. Katschinski, A. Neumann, Elke Jäger, Alexander Knuth, S.O. Peters, J. D. P. Van Dijk, H. I. Robins, J. Finet
Publikováno v:
Oncology. 64:312-321
Background: Based on earlier clinical and preclinical studies, we conducted a phase II trial in metastatic sarcoma patients of the combination of 41.8°C (×60 min) radiant heat (Aquatherm®) whole-body hyperthermia (WBH) with ‘ICE’ chemotherapy.
Autor:
H. I. Robins
Publikováno v:
Neuro-Oncology. 4:109-114
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 126:173-177
Although whole-body hyperthermia combined with specific genotoxic chemotherapy can be shown to enhance neoplastic cell killing without a concomitant rise in bone marrow toxicity, nephrotoxicity can become treatment-limiting. This study compares the k
Autor:
Dörthe M. Katschinski, H I Robins
Publikováno v:
International Journal of Cancer. 80:104-109
The effect of different temperatures (37-42.5 degrees C) on SN-38 (the active metabolite of CPT-11) cytotoxicity was examined in the human lung carcinoma cell lines H460 and Calu-6 as well as the murine fibrosarcoma cell line L929. The cytotoxicity o
Publikováno v:
Journal of Immunotherapy. 22:67-70
Previous in vitro studies of sarcoma and normal cell lines exposed to 41.8 degrees C (x 60 min) demonstrated selective increased expression of members of the heat shock protein (HSP) family 70 on the cell surface of the sarcoma cells only. One implic